Bg pattern

AMBROXOL ALDO-UNION 15 mg/2 ml ORAL SOLUTION OR CONCENTRATE FOR NEBULIZER INHALATION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use AMBROXOL ALDO-UNION 15 mg/2 ml ORAL SOLUTION OR CONCENTRATE FOR NEBULIZER INHALATION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Leaflet: information for the user

Ambroxol Aldo-Union 15 mg/2 ml oral solution or concentrate for inhalation by nebulizer

Ambroxol hydrochloride

Read the entire leaflet carefully before starting to take this medication, as it contains important information for you.

  • Keep this leaflet, as you may need to read it again. If you have any questions, consult your doctor or pharmacist.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this leaflet. See section 4.

Contents of the leaflet

  1. What is Ambroxol Aldo-Union and what is it used for
  2. What you need to know before taking Ambroxol Aldo-Union
  3. How to take Ambroxol Aldo-Union
  4. Possible side effects
  5. Storage of Ambroxol Aldo-Union
  6. Package contents and additional information

1. What is Ambroxol Aldo-Union and what is it used for

Ambroxol Aldo-Union contains the active ingredient ambroxol, which belongs to a group of medications called mucolytics used to facilitate the elimination of mucus from the respiratory tract.

Ambroxol Aldo-Union is indicated for the symptomatic treatment of acute and chronic bronchopulmonary processes with an excess of mucus production and viscosity, for adults and children from 2 years of age.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Ambroxol Aldo-Union

Do not take Ambroxol Aldo-Union:

  • if you are allergic to ambroxol or any of the other components of this medication (listed in section 6).
  • if you have a severe liver and/or kidney disease.
  • in children under 2 years of age.
  • if you are in the first trimester of pregnancy.

Warnings and precautions

Consult your doctor or pharmacist before taking Ambroxol Aldo-Union:

  • if you have stomach ulcers (peptic ulcer).
  • if you have mild or moderate kidney function impairment.
  • if you have severe liver problems.
  • during the first three months of pregnancy or if you are breastfeeding.

Consider:

There have been reports of severe skin reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) associated with the administration of ambroxol. Specifically, the initial phase of these diseases could manifest with symptoms similar to those of the flu, such as fever, pain, cold (rhinitis), cough, and sore throat.

If a skin rash appears (including lesions in the mouth, throat, nose, eyes, or genital mucosa), stop taking Ambroxol Aldo-Union and consult a doctor immediately.

If an irritating cough appears during the administration of the nebulized solution, try to inhale and exhale normally during inhalation. If you are particularly sensitive, you can pre-heat the solution to inhale to body temperature.

If you have bronchial asthma, it is advisable to administer a medication (bronchial spasmolytic) before inhalation.

Children

Ambroxol Aldo-Union should not be administered to children under 2 years of age, as mucolytics can cause respiratory tract obstruction (bronchi).

Use of Ambroxol Aldo-Union with other medications

Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.

Before taking Ambroxol Aldo-Union, inform your doctor that you are taking medications such as amoxicillin, cefuroxime, or erythromycin (antibiotics used to treat bacterial infections).

No interactions with other medications have been observed.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Pregnancy

Ambroxol Aldo-Union is not recommended during the first trimester. During the second and third trimesters, Ambroxol Aldo-Union should only be used after consulting a doctor and evaluating the risk/benefit ratio of each individual case.

Breastfeeding

Ambroxol Aldo-Union is excreted in breast milk, and therefore, its use is not recommended during breastfeeding.

Driving and using machines

Ambroxol Aldo-Union does not affect the ability to drive and use machines.

Ambroxol Aldo-Union containssodium

This medication contains less than 23 mg (1 mmol) per ampoule, so it is considered essentially "sodium-free"

3. How to take Ambroxol Aldo-Union

Follow the administration instructions of this medication exactly as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

Each single-dose ampoule contains 2 ml and includes a mark indicating a volume of 1 ml (half dose).

Nebulizer inhalation solution:

Adults and children over 5 years: 2 ml (1 ampoule) twice a day.

Children from 2 to 5 years: 1 ml - 2 ml (half ampoule - 1 ampoule), 1 or 2 times a day.

The solution can be administered using the aerosol therapy devices normally used. It can also be diluted in distilled water in a 1:1 ratio.

Oral solution:

Adults: 2 ml - 4 ml (1 - 2 ampoules), 3 times a day.

Children over 5 years: 1-2 ml (1/2 ampoule - 1 ampoule), 2 to 3 times a day.

Children from 2 to 5 years: 1 ml (half ampoule), 2 to 3 times a day.

Dilute the solution in a little water, tea, milk, or fruit juice. The medication should be taken with meals.

If you use half a dose, close the single-dose ampoule again by pressing the cap and store it in the refrigerator (2-8 °C) for a maximum of 12 hours.

If you take more Ambroxol Aldo-Union than you should

The risk of adverse reactions increases. In case of accidental ingestion/taking of an excessive dose of Ambroxol Aldo-Union, inform your doctor or go to the nearest hospital immediately.

If you forget to take Ambroxol Aldo-Union

Do not take a double dose to make up for forgotten doses.

If you interrupt treatment with Ambroxol Aldo-Union

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone experiences them.

Stop taking Ambroxol Aldo-Union immediately and consult a doctor if you experience any of the following disorders: itching, skin spots (urticaria, skin rash), swelling (angioedema) of the face, eyes, lips, and/or throat with difficulty breathing, due to allergy (hypersensitivity).

Other side effects:

Frequent(may affect up to 1 in 10 people):

  • alteration or decrease in taste (dysgeusia).
  • decreased sensitivity (hypoesthesia) in the mouth or pharynx (oral cavity).
  • nausea.

Uncommon(may affect up to 1 in 100 people):

  • vomiting.
  • diarrhea.
  • digestive difficulties (dyspepsia).
  • abdominal pain.
  • dry mouth.

Rare(may affect up to 1 in 1,000 people):

  • headache;
  • hypersensitivity reactions;
  • rash, urticaria.

Unknown:(frequency cannot be estimated from available data):

  • anaphylactic reactions, such as anaphylactic shock, angioedema (rapidly progressing swelling of the skin, subcutaneous tissue, mucous membranes, or submucosal tissues) and pruritus.
  • severe skin reactions (such as erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis, and acute generalized exanthematous pustulosis).
  • respiratory tract obstruction (bronchi).
  • throat dryness.

Reporting side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are possible side effects not listed in this leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Ambroxol Aldo-Union

Keep this medication out of sight and reach of children.

Do not use this medication after the expiration date shown on the box, aluminum pouch, or ampoule after "EXP". The expiration date is the last day of the month indicated.

Once the aluminum pouch is opened, the single-dose ampoules must be used within a maximum of three months, stored inside the pouch.

When using half a dose, the ampoule must be stored between 2-8 °C (in the refrigerator) and used within a maximum of 12 hours.

Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the pharmacy's SIGRE point. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.

6. Package contents and additional information

Composition of Ambroxol Aldo-Union

  • The active ingredient is ambroxol.
  • The other components are sodium chloride and water for injectable preparations.

Appearance of the product and package contents

Ambroxol Aldo-Union is presented in 2 ml low-density polyethylene single-dose ampoules, grouped in strips of 5 ampoules, packaged in an aluminum pouch.

It is available in packages of 15 or 30 ampoules of 2 ml.

Only some package sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

Laboratorio Aldo-Union, S.L.

Baronesa de Maldá, 73

08950 Esplugues de Llobregat

Barcelona - Spain

Manufacturer

GENETIC S.p.A.

Contrada Canfora

Fisciano (SA)

(Italy)

Date of the last revision of this leaflet:July 2020

Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) https://www.aemps.gob.es/

Online doctors for AMBROXOL ALDO-UNION 15 mg/2 ml ORAL SOLUTION OR CONCENTRATE FOR NEBULIZER INHALATION

Discuss questions about AMBROXOL ALDO-UNION 15 mg/2 ml ORAL SOLUTION OR CONCENTRATE FOR NEBULIZER INHALATION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for AMBROXOL ALDO-UNION 15 mg/2 ml ORAL SOLUTION OR CONCENTRATE FOR NEBULIZER INHALATION?
AMBROXOL ALDO-UNION 15 mg/2 ml ORAL SOLUTION OR CONCENTRATE FOR NEBULIZER INHALATION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in AMBROXOL ALDO-UNION 15 mg/2 ml ORAL SOLUTION OR CONCENTRATE FOR NEBULIZER INHALATION?
The active ingredient in AMBROXOL ALDO-UNION 15 mg/2 ml ORAL SOLUTION OR CONCENTRATE FOR NEBULIZER INHALATION is ambroxol. This information helps identify medicines with the same composition but different brand names.
Who manufactures AMBROXOL ALDO-UNION 15 mg/2 ml ORAL SOLUTION OR CONCENTRATE FOR NEBULIZER INHALATION?
AMBROXOL ALDO-UNION 15 mg/2 ml ORAL SOLUTION OR CONCENTRATE FOR NEBULIZER INHALATION is manufactured by Laboratorio Aldo Union S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of AMBROXOL ALDO-UNION 15 mg/2 ml ORAL SOLUTION OR CONCENTRATE FOR NEBULIZER INHALATION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether AMBROXOL ALDO-UNION 15 mg/2 ml ORAL SOLUTION OR CONCENTRATE FOR NEBULIZER INHALATION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to AMBROXOL ALDO-UNION 15 mg/2 ml ORAL SOLUTION OR CONCENTRATE FOR NEBULIZER INHALATION?
Other medicines with the same active substance (ambroxol) include AMBROXOL CINFA 3 mg/ml SYRUP, AMBROXOL CINFA 6 mg/ml SYRUP, AMBROXOL NORMON 3 mg/ml ORAL SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media